Breaking News

Nivagen Pharmaceuticals Sells MedisourceRx Business Unit to Hims & Hers

Positions the health and wellness company to enter the CDMO business.

Author Image

By: Charlie Sternberg

Associate Editor

Nivagen Pharmaceuticals, Inc., a specialty pharmaceuticals company, has sold its MedisourceRx business unit to Hims & Hers Health, Inc., a prominent health and wellness company. Bourne Partners served as the exclusive financial advisor to Nivagen in this transaction.   The MedisourceRx business unit is an FDA-registered 503B outsourcing facility. It will become a valuable asset to Hims & Hers as they continue to expand their offerings in the healthcare market. The proceeds from the sal...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters